- Home
- AVNS vs IMTX Comparison
AVNS vs IMTX Comparison
Compare AVNS & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVNS
- IMTX
- Stock Information
- Founded
- AVNS 2014
- IMTX N/A
- Country
- AVNS United States
- IMTX Germany
- Employees
- AVNS N/A
- IMTX N/A
- Industry
- AVNS Industrial Specialties
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AVNS Health Care
- IMTX Health Care
- Exchange
- AVNS Nasdaq
- IMTX Nasdaq
- Market Cap
- AVNS 641.7M
- IMTX 514.2M
- IPO Year
- AVNS N/A
- IMTX N/A
- Fundamental
- Price
- AVNS $12.43
- IMTX $4.26
- Analyst Decision
- AVNS Hold
- IMTX Strong Buy
- Analyst Count
- AVNS 1
- IMTX 4
- Target Price
- AVNS N/A
- IMTX $16.67
- AVG Volume (30 Days)
- AVNS 501.5K
- IMTX 849.5K
- Earning Date
- AVNS 05-01-2025
- IMTX 05-13-2025
- Dividend Yield
- AVNS N/A
- IMTX N/A
- EPS Growth
- AVNS N/A
- IMTX N/A
- EPS
- AVNS N/A
- IMTX 0.14
- Revenue
- AVNS $687,800,000.00
- IMTX $161,336,577.00
- Revenue This Year
- AVNS N/A
- IMTX N/A
- Revenue Next Year
- AVNS $3.36
- IMTX $18.80
- P/E Ratio
- AVNS N/A
- IMTX $29.39
- Revenue Growth
- AVNS 2.15
- IMTX 188.60
- 52 Week Low
- AVNS $11.90
- IMTX $3.30
- 52 Week High
- AVNS $25.36
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- AVNS 34.92
- IMTX 48.54
- Support Level
- AVNS $11.91
- IMTX $4.03
- Resistance Level
- AVNS $12.71
- IMTX $4.48
- Average True Range (ATR)
- AVNS 0.61
- IMTX 0.39
- MACD
- AVNS -0.08
- IMTX 0.05
- Stochastic Oscillator
- AVNS 20.15
- IMTX 75.00
About AVNS Avanos Medical Inc.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.